This provider's $20.1M in total Medicare payments ranks in the 99th percentile of Radiation Oncology providers nationally.
Their average markup ratio of 8.6x is significantly above the specialty median of 5.0x.
Medicare payments to this provider grew 1069% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 5352% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $1.1K | $103.70 | 10.38x | $972.67 | $167.0K | 3.2K | 1.1K |
| 2015 | $431.51 | $61.02 | 7.07x | $370.49 | $22.5K | 423 | 168 |
| 2016 | $1.2K | $191.71 | 6.35x | $1.0K | $1.2M | 3.9K | 1.3K |
| 2017 | $1.4K | $206.30 | 6.83x | $1.2K | $2.5M | 8.4K | 3.1K |
| 2018 | $1.4K | $202.72 | 6.73x | $1.2K | $2.8M | 9.5K | 3.0K |
| 2019 | $1.4K | $202.35 | 6.71x | $1.2K | $4.0M | 11.6K | 3.1K |
| 2020 | $1.5K | $254.44 | 5.80x | $1.2K | $2.8M | 8.7K | 2.4K |
| 2021 | $1.6K | $301.82 | 5.44x | $1.3K | $2.3M | 8.2K | 2.8K |
| 2022 | $1.9K | $319.84 | 5.82x | $1.5K | $2.3M | 8.3K | 2.7K |
| 2023 | $1.8K | $244.85 | 7.28x | $1.5K | $2.0M | 7.0K | 2.5K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 77523 | Proton treatment delivery, intermediate | 14.4K | $11.5M | $801.47 | 9.56x |
| 77525 | Proton treatment delivery, complex | 3.4K | $3.1M | $916.77 | 8.36x |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 18.3K | $1.1M | $61.35 | 10.33x |
| 77301 | Management of modulation radiotherapy planning | 507 | $772.4K | $1.5K | 4.15x |
| 77427 | Radiation treatment management, 5 treatments | 4.6K | $695.8K | $151.92 | 7.16x |
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 578 | $643.5K | $1.1K | 4.20x |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation | 1.9K | $303.7K | $158.16 | 1.01x |
| 77336 | Radiation therapy consultation per week | 4.0K | $260.9K | $66.00 | 5.20x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 121 | $254.1K | $2.1K | 3.35x |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 983 | $157.4K | $160.14 | 18.98x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 2.3K | $123.6K | $54.64 | 4.19x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 683 | $110.0K | $160.99 | 4.25x |
| 72197 | MRI scan of pelvis before and after contrast | 423 | $100.5K | $237.58 | 13.43x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 88 | $79.2K | $900.20 | 2.26x |
| 77263 | Management of radiation therapy, complex | 594 | $78.7K | $132.49 | 9.04x |
| 77280 | Management of radiation therapy simulation, simple | 344 | $76.4K | $221.98 | 2.81x |
| 77470 | Special radiation treatment procedure | 528 | $56.3K | $106.65 | 16.82x |
| 55876 | Insertion of radiation therapy devices in prostate gland for radiation therapy guidance | 483 | $53.9K | $111.50 | 4.20x |
| A4648 | Tissue marker, implantable, any type, each | 411 | $42.3K | $102.85 | 3.65x |
| 76872 | Ultrasound of rectum | 418 | $40.8K | $97.68 | 4.41x |
This provider submits charges 8.6 times higher than what Medicare actually pays.
A markup ratio of 8.6x means for every $100 Medicare pays, this provider initially charges $860. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data